1066
Molecules 2000, 5
Aqueous sodium hydroxide solution was added to the filtrate and products were extracted with dichlo-
romethane (6 ´ 20 mL). The combined organic phases were dried over sodium sulfate. After removal of the
solvent, the residue was purified by column chromatography (silica gel, ethyl acetate), and the resulting solid
1
was recrystallized from chloroform to give 10 (112 mg, 90%) as a white solid: mp 186-187°C; H NMR
(CDCl ) d=2.17 (1H, dm, J=14, 9-Hs), 3.00 (1H, dt, J=14 and 2, 9-Ha), 3.45 (2H, t, J=2, 5-H and 8-H),
3
3.99 (2H, br s, 6-H and 7-H), 4.15 (2H, s, OH, disappeared by D O addition), 8.16 (2H, s, 2-H and 3-H);
2
13C NMR (CDCl ) d=41.2 (C-5 and C-8), 51.4 (C-9), 69.7 (C-2 and C-3), 141.7 (C-6 and C-7), 161.1
3
-1
(C-4a and C-8a); IR (KBr) 3490, 3097, 1365, 1160 cm ; MS m/z 178 (33; M+), 149 (31; M - CHO), 119
(100, M - 2CHO - H). Anal. Found: C, 60.52; H, 5.96; N, 15.67%. Calcd for C H10N2O2: C, 60.66; H,
9
5.66; N, 15.72%.
1,2,3,4-Tetrahydro-1,4-methanophenazine-2-exo,3-exo-diol (11)
By a similar procedure as described for 10, the norbornadiene-fused quinoxaline 8 (349 mg, 1.8 mmol)
provided 11 (366 mg, 89%) as a white solid after recrystallization from chloroform: mp 183-184°C; 1H NMR
(CDCl ) d=2.23 (1H, dm, J=11, 11-Hs), 2.65 (1H, d, J=11, 11-Ha), 3.58 (2H, s, 1-H and 4-H), 3.77 (2H,
3
s, OH, disappeared by D2O addition), 4.14 (2H, s, 2-H and 3-H), 7.70 (2H, m, 7-H and 8-H), 8.00 (2H, m,
13
6-H and 9-H); C NMR (CDCl ) d=39.0 (C-1 and C-4), 51.3 (C-11), 76.3 (C-2 and C-3), 128.7 (C-7
3
and C-8), 129.4 (C-6 and C-9), 141.4 (C-5a and C-9a), 160.8 (C-4a and C-10a); IR (KBr) 3430, 3074,
-1
1076 cm ; MS m/z 228 (59; M+), 199 (31; M - CHO), 169 (100, M - 2CHO - H). Anal. Found: C, 68.41;
H, 5.30; N, 12.27%. Calcd for C13H12N2O2: C, 68.68, H, 5.21; N, 12.01%.
The Swern Oxidation of 10
To a cooled (-78°C) solution of dimethyl sulfoxide (125 mg, 1.6 mmol) in dichloromethane (10 mL) was
added trifluoroacetic anhydride (315 mg, 1.5 mmol) over 5 min. A solution of 10 (89 mg, 0.5 mmol) in a 1:1
mixture (5 mL) of dichloromethane and dimethyl sulfoxide was added over 10 min and the mixture was stirred
at -78°C for 3 h. Triethylamine (268 mg, 2.7 mmol) was introduced to the solution. The mixture was stirred at
-78°C for 1.5 h and allowed to warm up to room temperature. Aqueous sodium hydroxide solution was
added and the product was extracted with dichloromethane (6 ´ 20 mL). The combined organic phase was
washed with water and dried over sodium sulfate. After removal of the solvent, the residue was separated by
column chromatography (silica gel, ethyl acetate) to give (6,7-dihydro-5H-cyclopentapyrazin-5-yl)methanol
1
(12) (56 mg, 75%) as a colorless liquid: H NMR (CDCl ) d=1.98 (1H, ddd, J=19, 11 and 9, 6-H), 2.37
3
(1H, ddd, J=19, 8 and 6, 6-H), 3.07 (2H, dd, J=9 and 6, 7-H), 3.43 (1H, m, 5-H), 3.80-4.01 (3H, m,
13
CH2OH and OH), 8.24 (1H, br s, 2-H or 3-H), 8.30 (1H, br s, 3-H or 2-H); C NMR (CDCl ) d=24.2
3
(C-6), 30.8 (C-7), 45.1 (C-5), 64.9 (CH2OH), 141.6 (C-2 or C-3), 142.7 (C-3 or C-2), 159.9, 160.2; IR
-1
+
(KBr) 3347, 2946, 1388, 1160 cm ; MS m/z 150 (2; M ), 119 (100, M - CH2OH). HR-MS (FAB+)
found: 151.0899 (M + 1). Calcd for C8H10N2O: 151.0872 (M + 1).
The Swern Oxidation of 11
By a similar procedure as described for the oxidation of 10, the norbornadiene-fused quinoxaline 11 (114
mg, 0.5 mmol) provided (2,3-dihydro-1H-cyclopenta[b]quinolin-1-yl)methanol (13) (58 mg, 63%) as a white